StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
71
Publishing Date
2022 - 12 - 09
1
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
Sector
Finance
4
Finance and insurance
3
Health technology
71
Tags
Blood
1
Cancer
4
Candidate
1
Cell
1
Clearance
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Collaboration
2
Conference
18
Covid
1
Covid-19
1
Drug
1
Earnings
5
Europe
5
Events
18
Expansion
1
Financial
4
Financial results
4
Iph5201
2
Iph6101
1
Money
2
N/a
25
Natural
2
News
1
Ongoing
1
Payment
1
Pharma
63
Pharmaceutical
8
Phase 1
1
Phase 2
4
Phase 2b
1
Phase 3
1
Platform
2
Presentation
3
Product-news
1
Regulatory
2
Report
3
Research
1
Response
1
Results
10
Sanofi
4
Study
1
Therapeutics
1
Trial
9
Update
6
Year
1
Entities
Abbvie inc.
1
Amgen inc.
1
Argenx se
1
Astellas pharma inc
1
Astrazeneca plc
4
Biogen inc.
1
Bnp paribas
4
Bristol-myers squibb company
2
Denali therapeutics inc.
1
Eli lilly and company
1
Glaxosmithkline plc
1
Incyte corporation
1
Innate pharma s.a.
120
Innate pharma sa
80
Johnson & johnson
1
Morgan stanley
1
Novartis ag
1
Novo nordisk a/s
71
Sanofi
109
Svb financial group
1
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
1
Vertex pharmaceuticals incorporated
1
Zai lab limited
1
Symbols
ABBV
14
ABT
20
ALNY
25
ALPMF
3
ALPMY
3
ALT
2
AMGN
17
AMZN
2
AZN
30
AZNCF
20
BAX
8
BDX
12
BHC
2
BIIB
7
BLK
5
BMY
7
BNPQF
3
BNPQY
3
BSX
3
CMXHF
3
CRL
2
CSLLY
3
CTLT
2
DNLI
2
DXCM
3
EIGR
2
ENDP
5
ENDPQ
4
ENTX
2
GALT
3
GILD
10
GLAXF
21
GMAB
4
GSK
27
ICLR
5
IONS
3
IPHA
71
IPHYF
44
JNJ
44
LLY
83
LPCN
3
MDGL
3
MDT
14
NVO
632
NVS
28
NVSEF
27
PFE
11
PODD
11
REGN
4
RVP
4
SNY
139
SNYNF
100
TAK
15
TEVJF
15
TMO
4
TRUMF
9
TRUMY
9
VRTX
3
VTRS
7
ZEAL
9
Exchanges
Nasdaq
71
Nyse
71
Crawled Date
2022 - 12 - 09
1
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
Crawled Time
05:00
2
06:00
20
07:00
15
08:00
10
09:00
6
10:00
6
11:00
6
12:00
4
12:30
1
22:00
1
Source
www.biospace.com
46
www.globenewswire.com
25
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Novo nordisk a::S
symbols :
IPHA
save search
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
23.97%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.44%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published:
2023-03-16
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.02%
|
O:
-0.07%
H:
1.96%
C:
0.56%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-12.96%
|
O:
-1.4%
H:
0.03%
C:
-0.08%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.72%
|
O:
1.01%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-21.0%
|
O:
-6.11%
H:
3.54%
C:
0.69%
pharma
conference
year
financial
Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published:
2023-03-13
(Crawled : 09:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-13.15%
|
O:
-0.02%
H:
1.44%
C:
-0.51%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.07%
|
O:
-0.81%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-17.15%
|
O:
2.21%
H:
4.65%
C:
-1.66%
pharma
update
Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
Published:
2023-02-21
(Crawled : 10:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-13.36%
|
O:
0.55%
H:
0.77%
C:
0.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.23%
|
O:
0.79%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-23.51%
|
O:
-3.76%
H:
0.0%
C:
-0.65%
pharma
Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023
Published:
2023-02-07
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.19%
|
O:
-1.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-11.12%
|
O:
0.19%
H:
1.01%
C:
0.91%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.66%
|
O:
1.64%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-28.24%
|
O:
-0.74%
H:
2.52%
C:
1.33%
pharma
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Published:
2023-01-25
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-5.73%
|
O:
-0.92%
H:
1.41%
C:
1.41%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-12.29%
|
O:
-1.97%
H:
1.74%
C:
1.28%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.54%
|
O:
0.39%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-32.6%
|
O:
-0.28%
H:
1.66%
C:
-0.28%
clearance
expansion
pharma
collaboration
sanofi
Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Published:
2022-12-19
(Crawled : 07:00)
- globenewswire.com
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
21.31%
|
O:
21.77%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.49%
|
O:
1.54%
H:
0.51%
C:
-0.25%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-7.86%
|
O:
-1.82%
H:
0.23%
C:
-0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.43%
|
O:
1.14%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
28.42%
|
O:
35.79%
H:
10.85%
C:
2.71%
pharma
collaboration
natural
therapeutics
sanofi
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
Published:
2022-12-09
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.47%
|
O:
-0.89%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-3.98%
|
O:
1.97%
H:
0.41%
C:
-1.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.13%
|
O:
-0.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
19.02%
|
O:
3.41%
H:
2.83%
C:
0.0%
pharma
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
Published:
2022-12-01
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
21.07%
|
O:
5.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.71%
|
O:
2.64%
H:
2.88%
C:
2.88%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-1.52%
|
O:
1.25%
H:
0.2%
C:
-0.02%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
3.93%
|
O:
2.96%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
13.49%
|
O:
4.56%
H:
1.86%
C:
1.86%
iph5201
pharma
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
Published:
2022-11-07
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
6.43%
|
O:
-2.01%
H:
0.88%
C:
0.88%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
9.16%
|
O:
0.91%
H:
1.82%
C:
1.43%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
6.93%
|
O:
-0.46%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
12.44%
|
O:
-1.38%
H:
2.8%
C:
1.87%
pharma
conference
update
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published:
2022-11-04
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
6.86%
|
O:
-0.02%
H:
0.43%
C:
0.43%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
7.76%
|
O:
-0.25%
H:
0.11%
C:
-1.03%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
9.12%
|
O:
2.05%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
15.09%
|
O:
-4.27%
H:
8.9%
C:
6.93%
pharma
trial
results
platform
Innate Pharma to Participate in Upcoming Investor Conferences - November 02, 2022
Published:
2022-11-02
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
3.92%
|
O:
-2.21%
H:
0.0%
C:
-0.14%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
15.3%
|
O:
4.84%
H:
4.18%
C:
1.48%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
7.18%
|
O:
0.07%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
11.42%
|
O:
-5.48%
H:
2.42%
C:
-0.97%
pharma
Innate Pharma 2023 Financial Calendar
Published:
2022-10-20
(Crawled : 07:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
17.3%
|
O:
-0.35%
H:
1.28%
C:
-0.17%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
15.74%
|
O:
-1.19%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
17.31%
|
O:
0.0%
H:
2.4%
C:
1.92%
pharma
financial
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published:
2022-10-20
(Crawled : 07:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
17.3%
|
O:
-0.35%
H:
1.28%
C:
-0.17%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
15.74%
|
O:
-1.19%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
17.31%
|
O:
0.0%
H:
2.4%
C:
1.92%
DNLI
|
$15.98
-3.74%
-3.88%
1.5M
|
Health Technology
|
-42.59%
|
O:
-5.24%
H:
10.87%
C:
5.45%
pharma
report
financial
update
results
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
Published:
2022-09-23
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
21.97%
|
O:
5.45%
H:
0.0%
C:
-8.46%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
24.82%
|
O:
-0.53%
H:
0.81%
C:
0.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
18.6%
|
O:
-1.69%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-1.21%
|
O:
-2.02%
H:
0.41%
C:
-3.72%
ongoing
pharma
trial
phase 2
Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published:
2022-09-15
(Crawled : 06:00)
- biospace.com/
BNPQF
|
$68.558
-13.4%
400
|
Finance
|
40.23%
|
O:
-1.65%
H:
0.0%
C:
-2.85%
BNPQY
|
$34.61
-2.68%
100K
|
Finance and Insurance
|
38.96%
|
O:
-1.12%
H:
2.34%
C:
1.69%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
10.75%
|
O:
1.6%
H:
0.0%
C:
-6.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
16.82%
|
O:
-0.88%
H:
0.45%
C:
-0.87%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
14.72%
|
O:
0.4%
H:
0.84%
C:
0.37%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.81%
|
O:
3.25%
H:
0.0%
C:
0.0%
pharma
financial
update
results
Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
Published:
2022-09-08
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
20.77%
|
O:
-0.65%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
17.06%
|
O:
-0.72%
H:
1.61%
C:
1.55%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
15.66%
|
O:
-0.47%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.79%
|
O:
1.54%
H:
0.76%
C:
-1.52%
pharma
conference
update
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published:
2022-09-05
(Crawled : 08:00)
- biospace.com/
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
Email alert
Add to watchlist
pharma
platform
phase 2b
Innate Pharma to Participate in Upcoming Investor Conferences - Aug 23, 2022
Published:
2022-08-23
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
10.96%
|
O:
1.75%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
14.1%
|
O:
-0.86%
H:
0.4%
C:
-0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
12.3%
|
O:
-0.72%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-7.58%
|
O:
1.52%
H:
2.05%
C:
0.75%
pharma
Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
Published:
2022-08-01
(Crawled : 10:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
-16.14%
|
O:
-14.87%
H:
4.09%
C:
4.09%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.16%
|
O:
-3.9%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
4.71%
|
O:
-0.21%
H:
0.41%
C:
-0.73%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.36%
|
O:
-1.92%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-23.75%
|
O:
-11.25%
H:
0.0%
C:
-1.06%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.5%
|
O:
0.44%
H:
0.53%
C:
-1.31%
pharma
update
study
← Previous
1
2
3
4
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.